http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201490208-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
filingDate 2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201490208-A1
titleOfInvention TENOFOVIR ALAFENAMIDE GEMIFUMARATE
abstract Hemifumarate form 9 - [(R> 2 - [[(S) - [[(S> 1- (isopropoxycarbonyl] ethyl] amino] phenoxyphosphinyl] m) (tenofovir alafenamide) and antiviral therapy using tenofovir alafenamide hemifumarate (for example, therapy against HIV and anti-HBV).
priorityDate 2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410431024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574768

Total number of triples: 25.